Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/21/2007EP1670448B1 Hcv inhibiting sulfonamides
11/21/2007EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands
11/21/2007EP1623711B1 External patch containing estrogen and/or progestogen
11/21/2007EP1613584B1 Pharmaceutical formulations comprising highly pure bases of 3,3-diphenyl propylamine monoesters
11/21/2007EP1608381B1 Therapeutic and consmetic application for a composition containing lycopene
11/21/2007EP1585752B1 Polyene polyketides, processes for their production and their use as a pharmaceutical
11/21/2007EP1578425B1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/21/2007EP1572653B1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants
11/21/2007EP1534707B1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007EP1530559B1 Method and device for producing formic acid formates and use of said formates
11/21/2007EP1525223B1 Ox40 (=cd134) receptor agonists and therapeutic use
11/21/2007EP1523313B1 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4- 1-(pyridin-2-ylmethyl)piperidin-4-yl -1h-indol-3-yl -1h-pyrrole mono-hydrochloride
11/21/2007EP1505975B1 Compositions and method for treating infection in cattle and swine
11/21/2007EP1505964B1 Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
11/21/2007EP1482920B1 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
11/21/2007EP1474140B1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1474135B1 Indole, azaindole and related heterocyclic pyrrolidine derivatives
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1458368B1 Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007EP1443918B1 Calcium l-threonate for treating bone facture
11/21/2007EP1431284B1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/21/2007EP1427824B1 Use of microbiology non-viral substances for treating acne
11/21/2007EP1423102B1 Plaster for the treatment of dysfunctions and disorders of nail growth
11/21/2007EP1421062B1 Novel cyclohexyl sulphones
11/21/2007EP1405639B1 Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistic analgesic effect in mammals
11/21/2007EP1385498B1 Fatty acids as neutrophil survival and activation factors.
11/21/2007EP1370150B1 One-step process for preparing chewing gum
11/21/2007EP1363594B1 Cosmetic formulations containing flavonoid derivatives
11/21/2007EP1357917B9 Use of carbohydrates for eliminating intestinal infections in animals
11/21/2007EP1356071B1 Genetically engineered herpes virus for the treatment of cardiovascular disease
11/21/2007EP1315485B1 Cathartic composition
11/21/2007EP1313464B1 Method for treatment of reactive arthritis or bursitis
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1281711B1 Interstrand crosslinking agents for dna and compounds therefor
11/21/2007EP1267854B1 Highly selective inhibitors of the urokinase plasminogen activator
11/21/2007EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007EP1197226B1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
11/21/2007EP1150996B1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/21/2007EP1056728B1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
11/21/2007EP1019087B1 Ganglioside immunostimulating complexes and uses thereof
11/21/2007EP0904378B1 Hepatitis b monoclonal antibodies
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007CN200977328Y Foot health care sock for diabetes patient
11/21/2007CN101076539A Crystal and deforming shaped smilagenin
11/21/2007CN101076538A Steroids for cancer treatment
11/21/2007CN101076532A Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
11/21/2007CN101076531A Carboxylic acid peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101076529A Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101076527A Tricyclic anilide spirohydantoin cgrp receptor antagonists
11/21/2007CN101076526A Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
11/21/2007CN101076525A Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
11/21/2007CN101076524A Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/21/2007CN101076521A Process for producing muscarine receptor antagonist and intermediate therefor
11/21/2007CN101076520A Imidazoline derivatives having cb1-antagonistic activity
11/21/2007CN101076519A Amide compound and thrombopoietin receptor activator
11/21/2007CN101076518A 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides
11/21/2007CN101076517A Substituted piperidines as modulators of dopamine neurotransmission
11/21/2007CN101076516A Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/21/2007CN101076514A Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
11/21/2007CN101076511A Omega-phenyloctanamides
11/21/2007CN101076372A Use of compounds for the prevention of drug-induced cell toxicity
11/21/2007CN101076371A Novel pharmaceutical composition containing at least one dolastatin 10 derivative
11/21/2007CN101076362A Biodegradable and bioresorbable material for medical use
11/21/2007CN101076354A Carrier used for medicine giving for intestine
11/21/2007CN101076353A Releasable polymer conjugate based on aliphatic biodegradable joint
11/21/2007CN101076345A Medicine for preventing and curing human genital system disorder and method for manufacturing the same
11/21/2007CN101076344A Multi-purpose bio-material composition
11/21/2007CN101076343A Use of A2A adenosine receptor agonists
11/21/2007CN101076342A Antibiotic combinations for providing total solution to the treatment of infections
11/21/2007CN101076341A 酪蛋白激酶2反义疗法 Casein kinase 2 antisense therapy
11/21/2007CN101076340A GABA-steroid antagonists and their use for the treatment of cns disorders
11/21/2007CN101076339A Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neurodegenerative disorders
11/21/2007CN101076338A Treatment of aml
11/21/2007CN101076337A Compounds and their use for treating somatic mutation-related diseases
11/21/2007CN101076336A Novel curcumin analogues and uses thereof
11/21/2007CN101076335A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
11/21/2007CN101076334A Benzoureas having anti-diabetic activity
11/21/2007CN101076333A Pyrazolo-heteroaryl compounds useful to treat TNF-alpha and IL-1 mediated diseases
11/21/2007CN101076332A Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
11/21/2007CN101076331A Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists
11/21/2007CN101076330A Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
11/21/2007CN101076329A Methods for purifying trans-(-)-delta;9-tetrahydrocannabinol and trans-(+)-delta;9-tetrahydrocannabinol
11/21/2007CN101076328A Preventive or therapeutic agent for sleep disorder
11/21/2007CN101076327A Carbamate compounds for use in treating neurodegenerative disorders
11/21/2007CN101076326A Method of using adapalene in acne maintenance therapy
11/21/2007CN101076325A Medicinal composition of edible carboxylic-acid and/or its acid salts and caffeine and non-drug addiction coffee
11/21/2007CN101076324A Orally effective cannabinoid analogs
11/21/2007CN101076323A Medicine composition for treating fatmass
11/21/2007CN101076322A Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals
11/21/2007CN101076319A Pharmaceutical dosage forms of stable amorphous rapamycin like compounds
11/21/2007CN101076317A Method of reducing nosocomial infections
11/21/2007CN101076316A Composition and method for accelerating fibulin-5 production and/or enhancing fibulin-5 activity
11/21/2007CN101076252A Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
11/21/2007CN101076250A Neuroprotective spirostenol pharmaceutical compositions
11/21/2007CN101076248A Treatment using D-threo methylphenidate
11/21/2007CN101076247A Therapeutic immunization of HIV-infected individuals
11/21/2007CN101074447A Method for producing paeonin metabolite-I by short lactobacillin fermentation
11/21/2007CN101074271A Production and use for amphipathic chitose derivative
1 ... 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508 3509 3510 3511 3512 3513 3514 3515 ... 7860